Prudential Financial
NTLA icon

Prudential Financial’s Intellia Therapeutics NTLA Stock Holding History

Prudential Financial’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Buy
22,185
+4,655
+27% +$65.2K ﹤0.01% 2018
2026
Q1 		$225K Buy
+17,530
New +$223K ﹤0.01% 2105
2025
Q4 		– Sell
-13,294
Closed -$230K – 2364
2025
Q3 		$230K Sell
13,294
-145
-1% -$1.79K ﹤0.01% 2183
2025
Q2 		$158K Buy
+13,439
New +$110K ﹤0.01% 2246
2024
Q3 		– Sell
-23,739
Closed -$531K – 2772
2024
Q2 		$531K Buy
23,739
+298
+1% +$7.09K ﹤0.01% 2161
2024
Q1 		$645K Buy
23,441
+15,632
+200% +$434K ﹤0.01% 2058
2023
Q4 		$238K Buy
7,809
+125
+2% +$3.59K ﹤0.01% 2389
2023
Q3 		$243K Buy
7,684
+499
+7% +$19.4K ﹤0.01% 2332
2023
Q2 		$293K Buy
7,185
+568
+9% +$23K ﹤0.01% 2304
2023
Q1 		$357K Sell
6,617
-115
-2% -$4.51K ﹤0.01% 2218
2022
Q4 		$235K Buy
6,732
+204
+3% +$9.7K ﹤0.01% 2353
2022
Q3 		$361K Buy
6,528
+141
+2% +$8.75K ﹤0.01% 2217
2022
Q2 		$335K Sell
6,387
-16,568
-72% -$841K ﹤0.01% 2299
2022
Q1 		$1.67M Sell
22,955
-68,927
-75% -$5.84M ﹤0.01% 1614
2021
Q4 		$11M Buy
91,882
+25,060
+38% +$3.14M 0.01% 700
2021
Q3 		$9.11M Sell
66,822
-374
-0.6% -$56.6K 0.01% 762
2021
Q2 		$10.9M Buy
67,196
+9,792
+17% +$762K 0.01% 735
2021
Q1 		$4.61M Buy
57,404
+52,470
+1,063% +$3.52M 0.01% 1064
2020
Q4 		$269K Buy
+4,934
New +$179K ﹤0.01% 2277

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Prudential Financial's NTLA Position: Q2 2026 in Review

Prudential Financial increased its Intellia Therapeutics (NTLA) stake by 27% in Q2 2026, buying an estimated $65.2K and bringing the position to 22,185 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

Prudential Financial first reported a position in NTLA in Q4 2020 and has held it in 19 quarters since. The position peaked at $11M in Q4 2021. 329 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Prudential Financial held 22,185 shares of Intellia Therapeutics worth $375K as of Q2 2026.
  • Prudential Financial bought 4,655 Intellia Therapeutics shares in Q2 2026, an estimated $65.2K.
  • Intellia Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2018 holding.
  • Prudential Financial first reported a position in Intellia Therapeutics in Q4 2020 and has held it in 19 quarters since.
  • Prudential Financial's Intellia Therapeutics position peaked at $11M in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.